Charles A. Rowland Jr. - 13 Sep 2022 Form 4 Insider Report for Generation Bio Co. (GBIO)

Role
Director
Signature
/s/ Jennifer Elliott, Attorney-in-Fact
Issuer symbol
GBIO
Transactions as of
13 Sep 2022
Net transactions value
+$127,404
Form type
4
Filing time
15 Sep 2022, 16:07:16 UTC
Previous filing
13 Jun 2022
Next filing
19 Sep 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GBIO Common Stock Purchase $97,752 +18,784 +19% $5.20 119,819 13 Sep 2022 Direct F1
transaction GBIO Common Stock Purchase $29,652 +5,600 +4.7% $5.30 125,419 14 Sep 2022 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.08 to $5.33, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) of this Form 4.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.10 to $5.40, inclusive.